Pulmonary Arterial Hypertension in Patients with Sleep Apnoea Syndrome

Overview

Journal Thorax

Date 2000 Oct 26

PMID 11050263

Citations 45

Authors

E Bady

A Achkar

S Pascal

E Orvoen-Frija

J P Laaban

Affiliations

Soon will be listed here.

Abstract

Background: Pulmonary arterial hypertension (PAH) in patients with sleep apnoea syndrome (SAS) is classically ascribed to associated chronic obstructive pulmonary disease (COPD). The aim of this retrospective study was to evaluate the possible occurrence of PAH as a complication of SAS in patients without COPD.

Methods: Right heart catheterisation was performed in 44 patients with SAS and without COPD confirmed by polysomnography (apnoea index >5/h) admitted for the administration of nasal continuous positive airway pressure (CPAP).

Results: Precapillary PAH, defined as mean pulmonary arterial pressure of >20 mm Hg with pulmonary capillary wedge pressure <15 mm Hg, was observed in 12/44 (27%) patients with SAS. There were no significant differences in apnoea index between patients with (PAH+) and those without PAH (PAH-) (42.6 (26.3) versus 35.8 (21.7) apnoeas/h). The PAH+ group differed significantly from the PAH- group in the following respects: lower daytime arterial oxygen tension (PaO(2)) (9.6 (1.1) versus 11.3 (1.5) kPa, p=0.0006); higher daytime arterial carbon dioxide tension (PaCO(2)) (5.8 (0.5) versus 5.3 (0.5) kPa, p=0.002); more severe nocturnal hypoxaemia with a higher percentage of total sleep time spent at SaO(2) <80% (32.2 (28.5)% versus 10.7 (18.8)%, p=0.005); and higher body mass index (BMI) (37.4 (6) versus 30.3 (6.7) kg/m(2), p=0.002). The PAH+ patients had significantly lower values of vital capacity (VC) (87 (14)% predicted versus 105 (20)% predicted, p=0.005), forced expiratory volume in one second (FEV(1)) (82 (14)% predicted versus 101 (17)% predicted, p=0.001), expiratory reserve volume (40 (16)% predicted versus 77 (41)% predicted, p=0.003), and total lung capacity (87 (13)% predicted versus 98 (18)% predicted, p=0.04). Stepwise multiple regression analysis showed that mean pulmonary artery pressure (PAPm) was positively correlated with BMI and negatively with PaO(2).

Conclusion: Pulmonary arterial hypertension is frequently observed in patients with SAS, even when COPD is absent, and appears to be related to the severity of obesity and its respiratory mechanical consequences.

Citing Articles

Right ventricular responses to CPAP therapy in obstructive sleep apnea: CMR analysis of the MOSAIC randomized trial.

Samaranayake C, Turnbull C, Neubauer S, Kylintireas I, Stradling J, Craig S Pulm Circ. 2023; 13(1):e12201.

PMID: 36814585 PMC: 9939623. DOI: 10.1002/pul2.12201.

Deficiency Promotes Pulmonary Arterial Hypertension via HGF/c-Met Signaling.

Park C, Kim S, Yang H, Kim J, Schermuly R, Cho Y Circ Res. 2022; 131(10):792-806.

PMID: 36205124 PMC: 9612711. DOI: 10.1161/CIRCRESAHA.122.320845.

Comparison of Percutaneous Coronary Intervention Outcomes Among Patients With Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease Overlap, and Pickwickian Syndrome (Obesity Hypoventilation Syndrome).

Desai R, Sachdeva S, Jain A, Rizvi B, Fong H, Raina J Cureus. 2022; 14(5):e24816.

PMID: 35686280 PMC: 9170433. DOI: 10.7759/cureus.24816.

Utilization and in-hospital complications of catheter ablation for atrial fibrillation in patients with obesity and morbid obesity.

Prasitlumkum N, Chokesuwattanaskul R, Kaewput W, Thongprayoon C, Bathini T, Boonpheng B Clin Cardiol. 2022; 45(4):407-416.

PMID: 35170775 PMC: 9019886. DOI: 10.1002/clc.23795.

Predictive echocardiographic factors of severe obstructive sleep apnea.

Touil I, Amor H, Kechida M, Keskes Boudawara N, Brahem Y, Bouchareb S Pan Afr Med J. 2021; 38:359.

PMID: 34367438 PMC: 8308867. DOI: 10.11604/pamj.2021.38.359.28470.

References

Sajkov D, Cowie R, Thornton A, Espinoza H, McEvoy R . Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1994; 149(2 Pt 1):416-22. DOI: 10.1164/ajrccm.149.2.8306039. View

Bradley T . Right and left ventricular functional impairment and sleep apnea. Clin Chest Med. 1992; 13(3):459-79. View

Laks L, Lehrhaft B, Grunstein R, Sullivan C . Pulmonary hypertension in obstructive sleep apnoea. Eur Respir J. 1995; 8(4):537-41. View

Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R . Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest. 1996; 109(2):380-6. DOI: 10.1378/chest.109.2.380. View

Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M . Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J. 1996; 9(4):787-94. DOI: 10.1183/09031936.96.09040787. View

Laks L, Lehrhaft B, Grunstein R, Sullivan C . Pulmonary artery pressure response to hypoxia in sleep apnea. Am J Respir Crit Care Med. 1997; 155(1):193-8. DOI: 10.1164/ajrccm.155.1.9001311. View

Ahmed Q, Tomashefski Jr J . Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. Hum Pathol. 1997; 28(3):264-9. DOI: 10.1016/s0046-8177(97)90122-2. View

Sanner B, Doberauer C, Konermann M, Sturm A, Zidek W . Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med. 1997; 157(21):2483-7. View

Sajkov D, Wang T, Saunders N, Bune A, Neill A, McEvoy R . Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999; 159(5 Pt 1):1518-26. DOI: 10.1164/ajrccm.159.5.9805086. View

10.

Krieger B, de la Hoz R . Altitude-related pulmonary disorders. Crit Care Clin. 1999; 15(2):265-80, viii. DOI: 10.1016/s0749-0704(05)70054-3. View

11.

Coccagna G, Mantovani M, Brignani F, PARCHI C, Lugaresi E . Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy). 1972; 8(5):1159-72. View

12.

Tilkian A, Guilleminault C, Schroeder J, Lehrman K, Simmons F, Dement W . Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med. 1976; 85(6):714-9. DOI: 10.7326/0003-4819-85-6-714. View

13.

Kay J, Suyama K, Keane P . Effect of intermittent normoxia on muscularization of pulmonary arterioles induced by chronic hypoxia in rats. Am Rev Respir Dis. 1981; 123(4 Pt 1):454-8. DOI: 10.1164/arrd.1981.123.4.454. View

14.

Ray C, Sue D, Bray G, Hansen J, Wasserman K . Effects of obesity on respiratory function. Am Rev Respir Dis. 1983; 128(3):501-6. DOI: 10.1164/arrd.1983.128.3.501. View

15.

. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983; 19 Suppl 5:1-95. View

16.

Bradley T, Rutherford R, Grossman R, Lue F, Zamel N, Moldofsky H . Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985; 131(6):835-9. DOI: 10.1164/arrd.1985.131.6.835. View

17.

Fletcher E, Schaaf J, Miller J, Fletcher J . Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis. 1987; 135(3):525-33. DOI: 10.1164/arrd.1987.135.3.525. View

18.

Weitzenblum E, SCHRIJEN F, Colas des Francs V, Lockhart A . Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest. 1988; 94(4):772-8. DOI: 10.1378/chest.94.4.772. View

19.

Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J . Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis. 1988; 138(2):345-9. DOI: 10.1164/ajrccm/138.2.345. View

20.

Series F, Cormier Y, La Forge J . Role of lung volumes in sleep apnoea-related oxygen desaturation. Eur Respir J. 1989; 2(1):26-30. View